LifeMD (LFMD) to Release Earnings on Wednesday

LifeMD (NASDAQ:LFMDGet Free Report) will announce its earnings results after the market closes on Wednesday, May 8th. Analysts expect the company to announce earnings of ($0.13) per share for the quarter. Individual interested in listening to the company’s earnings conference call can do so using this link.

LifeMD (NASDAQ:LFMDGet Free Report) last announced its quarterly earnings results on Monday, March 11th. The company reported ($0.12) EPS for the quarter, beating analysts’ consensus estimates of ($0.14) by $0.02. The firm had revenue of $44.86 million for the quarter, compared to the consensus estimate of $40.65 million. On average, analysts expect LifeMD to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.

LifeMD Stock Up 0.2 %

Shares of LFMD opened at $12.51 on Monday. LifeMD has a 1 year low of $1.46 and a 1 year high of $12.80. The company has a quick ratio of 1.15, a current ratio of 1.22 and a debt-to-equity ratio of 3.22. The business’s 50 day simple moving average is $9.92 and its 200-day simple moving average is $7.97.

Wall Street Analyst Weigh In

Several research firms recently commented on LFMD. BTIG Research lifted their price target on LifeMD from $13.00 to $14.00 and gave the stock a “buy” rating in a research report on Tuesday, April 23rd. HC Wainwright increased their price target on LifeMD from $10.00 to $12.00 and gave the company a “buy” rating in a report on Thursday, January 11th. Five research analysts have rated the stock with a buy rating, According to MarketBeat, the company currently has an average rating of “Buy” and an average target price of $10.40.

Read Our Latest Report on LifeMD

LifeMD Company Profile

(Get Free Report)

LifeMD, Inc operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for medical care in the United States. The company offers telehealth platform comprising RexMD, a men's telehealth brand that provides access to virtual medical treatment for a variety of men's health needs from licensed physician; ShapiroMD that provides virtual medical treatment, prescription medications, patented doctor formulated OTC products, topical compounded medications, and medical devices treating male and female hair loss; NavaMD, a female-oriented tele-dermatology that offers virtual medical treatment from dermatologists and other providers; and prescription oral and compounded topical medications to treat aging and acne; and Cleared which provides personalized treatments for allergy, asthma and immunology, including in-home tests for both environmental and food allergies, prescriptions for allergies and asthma and immunotherapies for treating chronic allergies.

Read More

Earnings History for LifeMD (NASDAQ:LFMD)

Receive News & Ratings for LifeMD Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifeMD and related companies with MarketBeat.com's FREE daily email newsletter.